Biofrontera Stock Market Value
| BFRI Stock | USD 0.78 0 0.17% |
| Symbol | Biofrontera |
Is there potential for Biotechnology market expansion? Will Biofrontera introduce new products? Factors like these will boost the valuation of Biofrontera. Projected growth potential of Biofrontera fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Biofrontera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.50) | Revenue Per Share | Quarterly Revenue Growth (0.23) | Return On Assets | Return On Equity |
Understanding Biofrontera requires distinguishing between market price and book value, where the latter reflects Biofrontera's accounting equity. The concept of intrinsic value - what Biofrontera's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Biofrontera's price substantially above or below its fundamental value.
It's important to distinguish between Biofrontera's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biofrontera should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biofrontera's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Biofrontera 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biofrontera's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biofrontera.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Biofrontera on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Biofrontera or generate 0.0% return on investment in Biofrontera over 90 days. Biofrontera is related to or competes with Gelteq Limited, ProPhase Labs, Aytu BioScience, Evogene, Dogwood Therapeutics, Sensei Biotherapeutics, and Trinity Biotech. Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treat... More
Biofrontera Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biofrontera's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biofrontera upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 34.13 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 6.76 |
Biofrontera Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biofrontera's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biofrontera's standard deviation. In reality, there are many statistical measures that can use Biofrontera historical prices to predict the future Biofrontera's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.11) |
Biofrontera February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 3.44 | |||
| Coefficient Of Variation | (2,341) | |||
| Standard Deviation | 6.09 | |||
| Variance | 37.03 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 34.13 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 6.76 | |||
| Skewness | 1.57 | |||
| Kurtosis | 9.67 |
Biofrontera Backtested Returns
Biofrontera is dangerous at the moment. Biofrontera secures Sharpe Ratio (or Efficiency) of 0.0144, which signifies that the company had a 0.0144 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Biofrontera, which you can use to evaluate the volatility of the firm. Please confirm Biofrontera's Standard Deviation of 6.09, risk adjusted performance of (0.03), and Mean Deviation of 3.44 to double-check if the risk estimate we provide is consistent with the expected return of 0.0869%. Biofrontera has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 2.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biofrontera will likely underperform. Biofrontera right now shows a risk of 6.02%. Please confirm Biofrontera value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Biofrontera will be following its price patterns.
Auto-correlation | 0.39 |
Below average predictability
Biofrontera has below average predictability. Overlapping area represents the amount of predictability between Biofrontera time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biofrontera price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Biofrontera price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Biofrontera Correlation, Biofrontera Volatility and Biofrontera Performance module to complement your research on Biofrontera. For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Biofrontera technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.